Surgery for Liver Cancer with Allograft Blood Vessels
Author Information
Author(s): Chen Jun-Ze, Zhang Cheng, Su Rui-Ling, Jian Yong-Yuan, Huang Kai-Yong, Tan Xue-Lin, Chen Zhao, Liao Yong-Xin, Dong Chun-Qiang, Dong Kun
Primary Institution: Department of Organ Transplantation, the First Affiliated Hospital of Guangxi Medical University, Nanning, China
Hypothesis
Can ex vivo tumor resection and partial liver autotransplantation using pre-frozen allograft blood vessels provide a safe surgical option for cirrhotic patients with hepatocellular carcinoma?
Conclusion
The study suggests that the surgical technique may be a promising and relatively safe option for radical tumor resection in cirrhotic patients.
Supporting Evidence
- The surgical technique was performed on two cirrhotic patients with hepatocellular carcinoma.
- Both patients recovered well postoperation without severe complications.
- Clear margins of the tumor were confirmed by ex vivo resection.
- No tumor recurrence was observed during 3 months of follow-up.
Takeaway
Doctors used special blood vessels from donors to help two patients with liver cancer have surgery, and both patients did well after the operation.
Methodology
The study involved in vivo partial hepatectomy followed by ex vivo tumor resection and partial liver autotransplantation using pre-frozen allograft blood vessels.
Limitations
The surgical complexities and risk of cancer recurrence in the remaining cirrhotic liver.
Participant Demographics
Two male patients aged 54 and 39, both with a history of hepatitis B and cirrhosis.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website